Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$59,569,982
+$7,888,486 QoQ
Shares Held
236,727
-0.4% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
2.46%
of 13F equity value
Holder Rank
#334
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026RNC CAPITAL MANAGEMENT LLC holds $281,592,319 across 11 Drug Manufacturers - General names. ABBV ranks #2 (21.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
517,240 | $66,465,340 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
236,727 | $59,569,982 | |
| 3 | JNJ |
Johnson & Johnson
|
191,013 | $48,511,571 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
356,290 | $45,013,678 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
645,383 | $37,186,968 | |
| 6 | LLY |
ELI LILLY & Co
|
13,549 | $16,251,078 | |
| 7 | AZN |
Astrazeneca PLC
|
32,535 | $6,169,286 | |
| 8 | AMGN |
Amgen Inc
|
2,755 | $997,640 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $59,569,982 | 236,727 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $51,681,496 | 237,627 | Shares | Sole | 2026-08-06 | |
| 2025-12-31 | $56,893,553 | 248,998 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $57,152,870 | 246,838 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $46,052,322 | 248,100 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $51,974,997 | 248,067 | Shares | Sole | 2025-05-16 | |
| 2024-12-31 | $44,678,755 | 251,428 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $70,452,964 | 356,760 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $61,191,475 | 356,760 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $62,315,894 | 342,207 | Shares | Sole | 2024-08-07 | |
| 2023-12-31 | $59,627,651 | 384,769 | Shares | Sole | 2024-01-17 | |
| 2023-09-30 | $57,330,711 | 384,615 | Shares | Sole | 2023-12-27 | |
| 2023-06-30 | $54,557,162 | 404,937 | Shares | Defined | 2023-07-21 | |
| 2023-03-31 | $65,401,463 | 410,375 | Shares | Defined | 2023-04-21 | |
| 2022-12-31 | $69,118,496 | 427,687 | Shares | Defined | 2023-01-11 | |
| 2022-09-30 | $57,112,797 | 425,548 | Shares | Defined | 2022-10-18 | |
| 2022-06-30 | $64,685,441 | 422,339 | Shares | Defined | 2022-07-22 | |
| 2022-03-31 | $67,270,138 | 414,966 | Shares | Defined | 2022-07-22 | |
| 2021-12-31 | $79,733,404 | 588,873 | Shares | Defined | 2022-02-04 | |
| 2021-09-30 | $63,826,571 | 591,699 | Shares | Defined | 2021-11-02 | |
| 2021-06-30 | $66,003,998 | 585,973 | Shares | Defined | 2021-07-20 | |
| 2021-03-31 | $55,625,512 | 514,004 | Shares | Defined | 2021-04-26 | |
| 2020-12-31 | $56,099,882 | 523,564 | Shares | Defined | 2021-01-13 | |
| 2020-09-30 | $47,497,867 | 542,275 | Shares | Defined | 2020-12-03 | |
| 2020-06-30 | $56,949,014 | 580,047 | Shares | Defined | 2020-07-23 | |
| 2020-03-31 | $43,556,070 | 571,677 | Shares | Defined | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||